In this engaging discussion, Jonathan Sabbagh, founder of Journey Clinical and a former finance professional turned clinical psychologist, shares his insights on psychedelic-assisted therapy. He highlights the importance of collaboration between therapists and prescribers, revealing the challenges in creating effective care models. The conversation dives into the transformative potential of ketamine-assisted therapy and the pressing need for innovative healthcare solutions in mental health. Jonathan also explores opportunities in the evolving landscape of psychedelic treatments and the role of technology in advancing access to care.